Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biochemotherapy with Temozolomide for Metastatic Melanoma
NCT00505635Phase 2Terminated
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Mar 2007
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of temozolomide in melanoma, sponsored by University of Texas MD Anderson Cancer Center. Started Mar 2007; status: terminated.
02
Drugs
temozolomide
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT00505635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00505635.